Skip to content

Comparison of two methods of bowel feeding and continuous in intensive care patients

Comparison of the effect of two methods of bolus and continuous enteral feeding on biochemical and clinical indicators of trauma patients admitted to intensive care units

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100124003146N10
Enrollment
74
Registered
2022-07-19
Start date
2022-07-23
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Nutritional support in intensive care. Condition 2: Nutritional support in intensive care. Unspecified severe protein-calorie malnutrition Other disorders of lung

Interventions

Intervention 1: The enteral nutrition group will be the intervention group in a continuous manner. In the intervention group, enteral feeding will be done continuously (for 24 hours and in the form of

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Being hospitalized in the intensive care unit Intestinal feeding through the nasogastric tube is prescribed by a doctor Have stable and normal hemodynamic conditions. The patient has a head trauma.

Exclusion criteria

Exclusion criteria: Age over 60 years The patient has intravenous nutrition The patient has a kidney or liver disorder

Design outcomes

Primary

MeasureTime frame
Whole blood lymphocyte count. Timepoint: Before intervention, 3 and 7 days after intervention. Method of measurement: Blood analyzer.;Blood hemoglobin level. Timepoint: Before intervention, 3 and 7 days after intervention. Method of measurement: Blood analyzer.;Hematocrit level. Timepoint: Before intervention, 3 and 7 days after intervention. Method of measurement: Blood analyzer.;Blood urea level. Timepoint: Before intervention, 3 and 7 days after intervention. Method of measurement: Blood biochemistry test device.;Blood creatinine level. Timepoint: Before intervention, 3 and 7 days after intervention. Method of measurement: Blood biochemistry device.;Blood calcium level. Timepoint: Before intervention, 3 and 7 days after intervention. Method of measurement: Blood biochemistry device.;Blood phosphorus level. Timepoint: Before intervention, 3 and 7 days after intervention. Method of measurement: Blood biochemistry device.;Blood phosphorus level. Timepoint: Before intervention, 3 and 7 days after intervention. Method of measurement: Blood biochemistry device.;Blood cholesterol level. Timepoint: Before intervention, 3 and 7 days after intervention. Method of measurement: Blood biochemistry device.;Blood triglyceride levels. Timepoint: Before intervention, 3 and 7 days after intervention. Method of measurement: Blood biochemistry device.;Blood aspartate aminotransferase level. Timepoint: Before intervention, 3 and 7 days after intervention. Method of measurement: Blood biochemistry device.;Remaining volume in the stomach. Timepoint: Daily. Method of measurement: Gavage syringe(50 cc).;Level of Albumin. Timepoint: Before intervention, 3 and 7 days after intervention. Method of measurement: Blood biochemistry test device.;Number of intestinal excretions. Timepoint: daily. Method of measurement: checklist.;Occurrence of pulmonary aspiration. Timepoint: daily. Method of measurement: checklist.;Number of vomiting. Timepoint: daily. Method of measurement: checklist.;Stomach

Secondary

MeasureTime frame
Weaning from the ventilator. Timepoint: End of intervention. Method of measurement: Checklist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactIsmail Azizi-Fini

Kashan University of Medical Sciences

azizifinies@yahoo.com+98 31 5554 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026